Potential Indications – Multiple sclerosis Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Multiple sclerosis is an autoimmune disease linked to the presence of white matter lesions associated with chronic inflammation leading to demyelination. Active …
News
Vascular dementia
Potential Indications – Vascular dementia Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Vascular dementia is a neurodegenerative disease with multiple aetiologies. Damage to cerebral nervous tissue may be due to ischaemic lesions involving small …
Parkinson disease
Potential Indications – Parkinson disease Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Parkinson’s disease is a neurodegenerative disorder caused by the formation of a-synuclein protein aggregates in neurons and their death. Associated with this …
Alzheimer’s and related diseases
Potential Indications – Alzheimer’s and related diseases Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Alzheimer’s disease is a progressive neurodegenerative disorder affecting various brain regions. The pathophysiological process involves an accumulation of Aβ peptides …
[Context] Iron, iron accumulation and ferroptosis
Potential Indications [Context] Iron, iron accumulation and ferroptosis Dr ROCHE Stéphane Background to our series of articles “Biomedical applications of advanced technology of magnetic susceptibility” Intracerebral iron is involved in the formation and maintenance of neuronal networks and is essential …
How and why implement ISO27001?
How and why implement ISO27001? Committed to a quality approach involving information security management, Ventio has decided to follow the ISO 27001 standard, considered to be the benchmark in this field. Noémie Vang is a certified ‚Lead Implementer‘, enabling the …
Stephane Roche becomes CEO of Ventio
Stephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took up his new position as Chief Executive Officer of Ventio at the end of April 2024. This appointment recognises the work of a …
[Revue Polytechnique]
Imaging services at the cutting edge of innovation and with very high added value In March 2024 issue, „La Jaune & La Rouge“ magazine interviewed our CEO Ludovic de Rochefort about Ventio’s expertise, the importance of sharing healthcare data to …
Publikationen wissenschaftliche
Clinical Integration of Automated Processing for Brain QSM
Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness Pascal Spincemaille, Zhe Liu, Shun Zhang, Ilhami Kovanlikaya, Matteo Ippoliti, Marcus Makowski, Richard Watts, Ludovic de Rochefort, Vijay Venkatraman, Patricia Desmond, Mathieu D. Santin, Stéphane …
Clinical Integration of QSM into Neurosurgical Practice
Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice S. Kathleen Bandt, Ludovic de Rochefort, Weiwei Chen, Alexey V. Dimov, Pascal Spincemaille, Brian H. Kopell, Ajay Gupta, Yi Wang World Neurosurgery, Volume 122, February 2019, Pages e10-e19 …
APP Ab38 Ab40 in FTD
Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audrey, Roche, Stéphane, Gény, Christian, Bennys, Karim, Labauge, Pierre, Tholance, Yannick, Quadrio, Isabelle, Tiers, Laurent, Gor, Baptiste, Boulanghien, Justine, Chaulet, Chloé, Vighetto, Alain, Croisile, Bernard, Krolak-Salmon, Pierre, Perret-Liaudet, …
sAPP & Abeta in CSF
Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in human cerebrospinal fluid Audrey Gabelle, S. Roche, Christian Geny, Karim Bennys, Pierre Labauge, Yannick Tholance, Isabelle Quadrio, Laurent Tiers, Baptiste Gor, Chloé Chaulet, Alain Vighetto, …
Quantitative susceptibility map reconstruction
Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging Ludovic de Rochefort, Tian Liu, Bryan Kressler, Jing Liu, Pascal Spincemaille, Vincent Lebon, Jianlin Wu, Yi Wang Magnetic Resonance in Medicine, 2010 The …
Preanalytical guidelines
Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Roche, Y. Allory, A. Barthelaix, J.-L. Beaudeux, F. Berger, F. Betsou, J. Borg, A. Dupuy J. Garin, M. Quillard, G Lizard, K. Peoc’H, M. Riviere & P. Ducoroy …
Biomarkers in CSF
Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications cliniques dans les démences A Gabelle, S. Roche & S Lehmann Revue Neurologique, Volume 165, Issue 3, March 2009, Pages 213-222 Résumé : L’exactitude du diagnostic dans le champ …
Autoantibody in CSF
Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrospinal-fluid. Stéphane Roche, Yves Dauvilliers, Laurent Tiers, Carine Couderc, Marie-Thérèse Piva, Monique Provansal, Audrey Gabelle & Sylvain Lehmann Journal of Immunological Methods, Volume 338, Issues 1–2, 30 September 2008, …
Quantitative MR susceptibility mapping
Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field Ludovic de Rochefort, Ryan Brown, Martin R. Prince, Yi Wang Magnetic Resonance in Medecine, First published: 24 September 2008 Abstract Magnetic properties characterized by susceptibility and chemical …
Clinical proteomics in CSF
Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roche, Audrey Gabelle & Sylvain Lehmann Proteomics Clin Appl. 2008 Mar;2(3):428-36. Abstract : The cerebrospinal fluid (CSF) circulates within the CNS where it plays an essential physiological …

















